Adalta Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,615
Closed -$251K 99
2020
Q4
$251K Buy
+2,615
New +$251K 0.16% 60